Aurinia Pharmaceuticals
AUPH
#5245
Rank
A$1.77 B
Marketcap
$12.92
Share price
-2.98%
Change (1 day)
67.19%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2024 (TTM): A$17.48 Million

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are A$0.23 Billion. , an increase over its 2023 earnings that were of -A$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2024

Annual earnings

Year Earnings Change
2024 A$20.31 M-116.44%
2023 -A$0.13 Billion-31.8%
2022 -A$0.19 Billion-39.4%
2021 -A$0.3 Billion61.9%
2020 -A$0.19 Billion-9.73%
2019 -A$0.21 Billion92.65%
2018 -A$0.11 Billion36.39%
2017 -A$77.85 Million106.29%
2016 -A$37.74 Million-15.4%
2015 -A$44.61 Million65.84%
2014 -A$26.9 Million129.82%
2013 -A$11.71 Million-26.6%
2012 -A$15.95 Million
2010 -A$9.03 Million-39.22%
2009 -A$14.86 Million-43.78%
2008 -A$26.42 Million-53.19%
2007 -A$56.44 Million42.97%
2006 -A$39.48 Million-23.03%
2005 -A$51.3 Million36.1%
2004 -A$37.69 Million172.57%
2003 -A$13.83 Million484.61%
2002 -A$2.37 Million
2000 -A$11.24 Million453.81%
1999 -A$2.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$7.90 B 38,814.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$9.07 Million-144.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$36.59 Million-280.09%๐Ÿ‡บ๐Ÿ‡ธ USA